268 related articles for article (PubMed ID: 30969799)
1. Mathematical Approach to Differentiate Spontaneous and Induced Evolution to Drug Resistance During Cancer Treatment.
Greene JM; Gevertz JL; Sontag ED
JCO Clin Cancer Inform; 2019 Apr; 3():1-20. PubMed ID: 30969799
[TBL] [Abstract][Full Text] [Related]
2. Modeling multi-mutation and drug resistance: analysis of some case studies.
Feizabadi MS
Theor Biol Med Model; 2017 Mar; 14(1):6. PubMed ID: 28327183
[TBL] [Abstract][Full Text] [Related]
3. Evolution of resistance to cancer therapy.
Michor F; Nowak MA; Iwasa Y
Curr Pharm Des; 2006; 12(3):261-71. PubMed ID: 16454743
[TBL] [Abstract][Full Text] [Related]
4. Interplay of Darwinian Selection, Lamarckian Induction and Microvesicle Transfer on Drug Resistance in Cancer.
Álvarez-Arenas A; Podolski-Renic A; Belmonte-Beitia J; Pesic M; Calvo GF
Sci Rep; 2019 Jun; 9(1):9332. PubMed ID: 31249353
[TBL] [Abstract][Full Text] [Related]
5. Perturbation-Driven Entropy as a Source of Cancer Cell Heterogeneity.
Nijman SMB
Trends Cancer; 2020 Jun; 6(6):454-461. PubMed ID: 32460001
[TBL] [Abstract][Full Text] [Related]
6. Calculated resistance in cancer.
Sawyers CL
Nat Med; 2005 Aug; 11(8):824-5. PubMed ID: 16079872
[No Abstract] [Full Text] [Related]
7. An elementary approach to modeling drug resistance in cancer.
Tomasetti C; Levy D
Math Biosci Eng; 2010 Oct; 7(4):905-18. PubMed ID: 21077714
[TBL] [Abstract][Full Text] [Related]
8. Multiple paths to a drug resistance phenotype: mutations, translocations, deletions and amplification of coding genes or promoter regions, epigenetic changes and microRNAs.
Fojo T
Drug Resist Updat; 2007; 10(1-2):59-67. PubMed ID: 17350322
[TBL] [Abstract][Full Text] [Related]
9. Mathematical modeling of drug resistance due to KRAS mutation in colorectal cancer.
Sameen S; Barbuti R; Milazzo P; Cerone A; Del Re M; Danesi R
J Theor Biol; 2016 Jan; 389():263-73. PubMed ID: 26551156
[TBL] [Abstract][Full Text] [Related]
10. Toward a Better Understanding of the Complexity of Cancer Drug Resistance.
Gottesman MM; Lavi O; Hall MD; Gillet JP
Annu Rev Pharmacol Toxicol; 2016; 56():85-102. PubMed ID: 26514196
[TBL] [Abstract][Full Text] [Related]
11. Evolution of acquired resistance to anti-cancer therapy.
Foo J; Michor F
J Theor Biol; 2014 Aug; 355():10-20. PubMed ID: 24681298
[TBL] [Abstract][Full Text] [Related]
12. Cancer therapy: an evolved approach.
Willyard C
Nature; 2016 Apr; 532(7598):166-8. PubMed ID: 27075079
[No Abstract] [Full Text] [Related]
13. How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine.
Gerlinger M; Swanton C
Br J Cancer; 2010 Oct; 103(8):1139-43. PubMed ID: 20877357
[TBL] [Abstract][Full Text] [Related]
14. Evolutionary scalpels for dissecting tumor ecosystems.
Rosenbloom DIS; Camara PG; Chu T; Rabadan R
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):69-83. PubMed ID: 27923679
[TBL] [Abstract][Full Text] [Related]
15. Enigmas in tumor resistance to kinase inhibitors and calculation of the drug resistance index for cancer (DRIC).
Smith CIE
Semin Cancer Biol; 2017 Aug; 45():36-49. PubMed ID: 27865897
[TBL] [Abstract][Full Text] [Related]
16. The stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cells.
Hansen SN; Ehlers NS; Zhu S; Thomsen MB; Nielsen RL; Liu D; Wang G; Hou Y; Zhang X; Xu X; Bolund L; Yang H; Wang J; Moreira J; Ditzel HJ; Brünner N; Schrohl AS; Stenvang J; Gupta R
BMC Genomics; 2016 Jun; 17():442. PubMed ID: 27277198
[TBL] [Abstract][Full Text] [Related]
17. Taking advantage of drug resistance, a new approach in the war on cancer.
Wang L; Bernards R
Front Med; 2018 Aug; 12(4):490-495. PubMed ID: 30022460
[TBL] [Abstract][Full Text] [Related]
18. Mathematical modeling and computational prediction of cancer drug resistance.
Sun X; Hu B
Brief Bioinform; 2018 Nov; 19(6):1382-1399. PubMed ID: 28981626
[TBL] [Abstract][Full Text] [Related]
19. Addressing intra-tumoral heterogeneity and therapy resistance.
Rybinski B; Yun K
Oncotarget; 2016 Nov; 7(44):72322-72342. PubMed ID: 27608848
[TBL] [Abstract][Full Text] [Related]
20. Mapping the Pathways of Resistance to Targeted Therapies.
Wood KC
Cancer Res; 2015 Oct; 75(20):4247-51. PubMed ID: 26392071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
